Roche wins UK watchdog's nod for lymphoma drug after initial snub
ZURICH (Reuters) - Britain's healthcare watchdog (NICE) recommended Roche's medicine Gazyvaro for previously untreated advanced follicular lymphoma patients after initially rejecting the Swiss drugmaker's medicine last year as too expensive. (Source: Reuters: Health)
Source: Reuters: Health - February 9, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Report of the Meeting on Sustainable Local Production of Influenza Vaccines for Pandemic Preparedness: Synergies with Other International Efforts and Improvement of the Current Tool
World Health Organization. 10/2017 This Web page provides documents from a meeting of stakeholders and experts held in Geneva, Switzerland, in June, 2017, to review each section of the sustainability checklist tool developed to help countries identify and address potential threats to the sustainability of their new production capacity for local influenza vaccines; identify the tool's strengths and weaknesses; and suggest improvements. The meeting also aimed to highlight synergies with other preparedness initiatives and identify opportunities for collaboration. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medici...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - February 7, 2018 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Influenza Vaccine Response During the Start of a Pandemic: Report of the Second WHO (World Health Organization) Informal Consultation Held in Geneva, Switzerland; 21 July-22 July 2016
World Health Organization. 03/2017 This 33-page document summarizes a meeting held in July, 2016, to follow up on a 2015 meeting to address questions associated with vaccine response at the start of an influenza pandemic and the problems associated with switching from seasonal influenza vaccine production to pandemic vaccine production. This meeting was held to bridge these gaps by better understanding the complexities of the early stages of pandemic vaccine development; elaborating the principles that could guide the decision to switch; and obtaining a better understanding of the evidence or data needed to support the dec...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - February 7, 2018 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Roche notches fresh win amid crowd of immunotherapy cocktails
ZURICH (Reuters) - Roche's Tecentriq mixed with an older drug cut the risk of death in kidney cancer, marking another win for the Swiss drugmaker's immuno-oncology (I/O) cocktail as it battles better-established medicines made by its rivals. (Source: Reuters: Health)
Source: Reuters: Health - February 6, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Seattle biotech PhaseRx sold to Swiss buyer in bankruptcy case
Seattle-based PhaseRx Inc. went public in May 2016 and filed for Chapter 11 bankruptcy protection in December 2017. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 5, 2018 Category: Biotechnology Authors: Casey Coombs Source Type: news

Seattle biotech PhaseRx sold to Swiss buyer in bankruptcy case
Seattle-based PhaseRx Inc. went public in May 2016 and filed for Chapter 11 bankruptcy protection in December 2017. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 5, 2018 Category: American Health Authors: Casey Coombs Source Type: news

Highlighting Yale science at the World Economic Forum
President Peter Salovey and other Yale luminaries joined experts from around the globe at the World Economic Forum (WEF), held Jan. 23-26 in Davos, Switzerland. (Source: Yale Science and Health News)
Source: Yale Science and Health News - February 5, 2018 Category: Universities & Medical Training Source Type: news

Diabetes patients are twice as likely to develop cataracts
The study, which found female diabetics had a higher risk, involved a team of researchers from Anglia Ruskin University, University Hospitals Bristol, Switzerland and Boston University. (Source: the Mail online | Health)
Source: the Mail online | Health - February 5, 2018 Category: Consumer Health News Source Type: news

Is this the global pandemic experts are warning about? They say it will be unstoppable because of the ease of travel
(Natural News) How prepared is the world to take on another pandemic? Not very, according to two of the world’s foremost experts on the subject. Speaking at the recently concluded World Economic Forum in Davos, Switzerland, Dr. Sylvie Briand, a specialist in infectious diseases from the World Health Organization (WHO) and Elhadj As Sy, the... (Source: NaturalNews.com)
Source: NaturalNews.com - February 3, 2018 Category: Consumer Health News Source Type: news

Zurich ’s Air Medical Program Flies Seven ECMO Missions in Ten Days
In a ten day period in January, Rega aircraft in Zurich, Switzerland transported and cared for a total of seven patients, including a two-year-old child, with the most severe cardiovascular and pulmonary disease. This was made possible by a small, portable heart-lung extracorporeal membrane oxygenation (ECMO) machine, which is compatible with both the ambulance jets, and the two types of helicopters used by Rega. Since 2009, Rega has been the only air rescue organization in Switzerland to have its own ECMO equipment. The devices have been instrumental in the care and transport of 25 intensive care patients annually. That&r...
Source: JEMS Operations - February 1, 2018 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT P Tags: Cardiac & Resuscitation Patient Care Operations Source Type: news

Zurich ’s Air Medical Program Flies Seven ECMO Missions in Ten Days
In a ten day period in January, Rega aircraft in Zurich, Switzerland transported and cared for a total of seven patients, including a two-year-old child, with the most severe cardiovascular and pulmonary disease. This was made possible by a small, portable heart-lung extracorporeal membrane oxygenation (ECMO) machine, which is compatible with both the ambulance jets, and the two types of helicopters used by Rega. Since 2009, Rega has been the only air rescue organization in Switzerland to have its own ECMO equipment. The devices have been instrumental in the care and transport of 25 intensive care patients annually. That&r...
Source: JEMS Patient Care - February 1, 2018 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT P Tags: Cardiac & Resuscitation Patient Care Operations Source Type: news

Zurich ’s Air Medical Program Flies Seven ECMO Missions in Ten Days
In a ten day period in January, Rega aircraft in Zurich, Switzerland transported and cared for a total of seven patients, including a two-year-old child, with the most severe cardiovascular and pulmonary disease. This was made possible by a small, portable heart-lung extracorporeal membrane oxygenation (ECMO) machine, which is compatible with both the ambulance jets, and the two types of helicopters used by Rega. Since 2009, Rega has been the only air rescue organization in Switzerland to have its own ECMO equipment. The devices have been instrumental in the care and transport of 25 intensive care patients annually. That&r...
Source: JEMS Operations - February 1, 2018 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT P Tags: Cardiac & Resuscitation Patient Care Operations Source Type: news

Zurich ’s Air Medical Program Flies Seven ECMO Missions in Ten Days
In a ten day period in January, Rega aircraft in Zurich, Switzerland transported and cared for a total of seven patients, including a two-year-old child, with the most severe cardiovascular and pulmonary disease. This was made possible by a small, portable heart-lung extracorporeal membrane oxygenation (ECMO) machine, which is compatible with both the ambulance jets, and the two types of helicopters used by Rega. Since 2009, Rega has been the only air rescue organization in Switzerland to have its own ECMO equipment. The devices have been instrumental in the care and transport of 25 intensive care patients annually. That&r...
Source: JEMS Patient Care - February 1, 2018 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT P Tags: Cardiac & Resuscitation Patient Care Operations Source Type: news

Journal Highlights From the February Issue of JAMDA
Older individuals who are caregivers have a shorter recovery following hip fracture than those individuals who are not, according to results from a study in Switzerland. (Source: Caring for the Ages)
Source: Caring for the Ages - January 31, 2018 Category: Health Management Source Type: news

Roche Chairman Sees Opportunities for Drugmakers Under Trump Roche Chairman Sees Opportunities for Drugmakers Under Trump
Fears U.S. President Donald Trump could damage the drugs industry have not been realized and the administration's efforts to accelerate new medicine approvals will bolster the sector, the chairman of Swiss drugmaker Roche said.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 29, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Correlates of weekday compliance to physical activity recommendations in Swiss youth non-compliant in weekend days - Gubelmann C, Marques-Vidal P, Bringolf-Isler B, Suggs LS, Vollenweider P, Kayser B.
Some children are inactive on weekends but active on weekdays. Correlates of such behavior remain to be clarified. We assessed school, out-of-school and family correlates of compliance with physical activity (PA) recommendations during weekdays among weeke... (Source: SafetyLit)
Source: SafetyLit - January 29, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Behavioral effects of the combined use of alcohol and energy drinks on alcohol hangover in an experimental mice model - Asorey LG, Carbone S, Gonzalez BJ, Cutrera RA.
In last few years it has been a significant increase in the consumption of alcohol combined with energy drink. The aim of this work was to study the effect of this mixture in motor and affective behaviors during an alcohol hangover episode. Male Swiss mice... (Source: SafetyLit)
Source: SafetyLit - January 29, 2018 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Roche wins FDA's breakthrough therapy label for autism drug
ZURICH (Reuters) - Swiss drugmaker Roche said on Monday the U.S. Food and Drug Administration granted its breakthrough therapy designation for Balovaptan to treat autism spectrum disorder (ASD), potentially accelerating its development and approval. (Source: Reuters: Health)
Source: Reuters: Health - January 29, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Roche wins FDA's breakthrough therapy designation for autism drug
ZURICH (Reuters) - Swiss drugmaker Roche said on Monday the U.S. Food and Drug Administration granted its breakthrough therapy designation for Balovaptan to treat autism spectrum disorder (ASD), potentially accelerating its development and approval. (Source: Reuters: Health)
Source: Reuters: Health - January 29, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Roche wins EU panel's recommendation for hemophilia drug
ZURICH (Reuters) - A European Union panel on Friday recommended approval of Roche's Hemlibra to treat hemophilia in some patients after the Swiss drugmaker got the green light last year to begin selling the medicine in the United States. (Source: Reuters: Health)
Source: Reuters: Health - January 26, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Roche chairman sees opportunities for drugmakers under Trump
ZURICH (Reuters) - Fears U.S. President Donald Trump could damage the drugs industry have not been realized and the administration's efforts to accelerate new medicine approvals will bolster the sector, the chairman of Swiss drugmaker Roche said. (Source: Reuters: Health)
Source: Reuters: Health - January 26, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Asia Reclaims Position as Epicenter of Global Innovation
Asia has reclaimed its standing as the epicenter for global innovation after briefly falling behind the United States in 2016, according to the 2017 Top 100 Global Innovators report issued today by Clarivate Analytics. The annual report highlights the most successful organizations in the world that are active in innovation through research and development, protection of their IP and the achievement of commercial success. It also reinforces a prevailing trend among innovative businesses of prioritizing investment in unique, enduring inventions – for which patents are successfully brought to market and enjoy greater gl...
Source: News from STM - January 25, 2018 Category: Databases & Libraries Authors: STM Publishing News Tags: Featured World Source Type: news

Nigeria:Niger State, Roche Sign MOU to Fight Breast Cancer
[This Day] The Niger State Government has signed a memorandum of understanding with Swiss multinational, Roche and Raise Foundation to provide high quality drugs and provide free treatment for breast cancer patients in the state. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 25, 2018 Category: African Health Source Type: news

Spark licenses blindness gene therapy rights outside U.S. to Novartis
(Reuters) - Spark Therapeutics Inc, whose breakthrough gene therapy to treat a rare form of blindness was approved by U.S. regulators in December, has licensed rights to the drug in markets outside the United States to Switzerland-based Novartis AG, it said on Wednesday. (Source: Reuters: Health)
Source: Reuters: Health - January 24, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Cancer could be spotted by wearable technology, says Nokia
The scanning device will pick up on biomarkers that indicate abnormal cell growth, according to comments made  by Rajeev Suri at the World Economic Forum in Davos, Switzerland. (Source: the Mail online | Health)
Source: the Mail online | Health - January 24, 2018 Category: Consumer Health News Source Type: news

Nerve cells found to be ‘unexpected helpers’ in wound healing
Ground-breaking research showing that nerve cells in the skin help wounds to heal may lead to an “effective treatment for chronic wounds” in the future, according to Swiss researchers. (Source: Nursing Times)
Source: Nursing Times - January 24, 2018 Category: Nursing Source Type: news

Novartis says Entresto could become $5 billion a year blockbuster drug
ZURICH (Reuters) - A Novartis executive said the Swiss company's heart failure medicine Entresto could be used more widely in future, potentially making it a blockbuster drug with revenue potential of $4 billion to $5 billion a year. (Source: Reuters: Health)
Source: Reuters: Health - January 24, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Reminder: Invitation to Roche's Full Year Results 2017 Presentation
Roche will publish its Full Year Results for 2017 prior to the opening of the Swiss Stock Exchange on Thursday, 1 February 2018. (Source: Roche Investor Update)
Source: Roche Investor Update - January 24, 2018 Category: Pharmaceuticals Source Type: news

Global Health: New Index Rates Drug Companies in Fight Against ‘ Superbugs ’
Glaxo and Johnson& Johnson top a new measure of how drugmakers do against antibiotic-resistant bacteria, which are becoming a global emergency. (Source: NYT Health)
Source: NYT Health - January 23, 2018 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Antibiotics Drugs (Pharmaceuticals) Antibiotic-Resistant Bacteria Antimicrobial Resistance World Health Organization Access to Medicines Foundation Davos (Switzerland) Tedros Adhanom Ghebreyesus Source Type: news

Bracco Imaging explores using microbubbles to deliver personalized gene therapy
Bracco Imaging has launched a new effort at its Switzerland-based R&D center to evaluate gas-filled microbubbles, usually used for diagnostic imaging, as a delivery vehicle for personalized gene therapies to treat chronic dysfunctional diseases linked to lipid metabolism. The research project is part of a deal that Bracco signed with startup SonoGene, which is developing platforms for the therapeutic delivery of genes and drugs using ultrasound-triggered microbubble delivery systems. Get the full story at our sister site, Drug Delivery Business News. The post Bracco Imaging explores using microbubbles to deliver p...
Source: Mass Device - January 23, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diagnostics Drug-Device Combinations Imaging Pharmaceuticals Research & Development Bracco Diagnostics Source Type: news

Reducing car dependence in the heart of Europe: lessons from Germany, Austria, and Switzerland - Buehler R, Pucher J, Gerike R, Gotschi T.
Munich, Berlin, Hamburg, Vienna, and Zurich - the largest cities in Germany, Austria, and Switzerland - have significantly reduced the car share of trips over the past 25 years in spite of high motorisation rates. The key to their success has been a coordi... (Source: SafetyLit)
Source: SafetyLit - January 23, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Medical News Today: 'Cross-dressing' cells may improve cancer treatment
Researchers from Switzerland describe a new method that improves cancer immunotherapy by 'cross-dressing' the dendritic cells of the immune system. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 23, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Perceptions of elder abuse from community-dwelling older persons and professionals working in western Switzerland - Roulet Schwab D, Wangmo T.
This study explored the views of older pe... (Source: SafetyLit)
Source: SafetyLit - January 23, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

European science on the map at Davos summit
(European Research Council) The European Research Council (ERC) will bring cutting-edge science to the forefront at the Annual Meeting of the World Economic Forum (WEF) from 23 to 26 January in Davos, Switzerland. Using ideas arising from this year's meeting theme: 'Creating a shared future in a fractured world', the ERC's President, Professor Jean-Pierre Bourguignon, and eleven remarkable scientists and scholars will feed into the debate, via fourteen sessions. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 22, 2018 Category: Infectious Diseases Source Type: news

Algorithm increases employment opportunities for refugees
(ETH Zurich) A data-driven approach could help increase employment levels for asylum seekers in Switzerland from 15 to 26 percent. Social scientists from Switzerland and the US, in collaboration with ETH's Public Policy Group, reached this conclusion in the journal Science. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - January 19, 2018 Category: International Medicine & Public Health Source Type: news

Improving refugee integration through data-driven algorithmic assignment
Developed democracies are settling an increased number of refugees, many of whom face challenges integrating into host societies. We developed a flexible data-driven algorithm that assigns refugees across resettlement locations to improve integration outcomes. The algorithm uses a combination of supervised machine learning and optimal matching to discover and leverage synergies between refugee characteristics and resettlement sites. The algorithm was tested on historical registry data from two countries with different assignment regimes and refugee populations, the United States and Switzerland. Our approach led to gains o...
Source: ScienceNOW - January 18, 2018 Category: Science Authors: Bansak, K., Ferwerda, J., Hainmueller, J., Dillon, A., Hangartner, D., Lawrence, D., Weinstein, J. Tags: Sociology reports Source Type: news

Novartis's Kymriah wins speedy reviews in U.S., Europe
ZURICH (Reuters) - Novartis has been granted fast-track reviews of its cell therapy Kymriah for blood cancers in the United States and Europe, the Swiss drugmaker said on Wednesday, as it seeks to expand the pool of patients eligible for the costly treatment. (Source: Reuters: Health)
Source: Reuters: Health - January 17, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Novartis gets U.S. priority review for Kymriah for adults with lymphoma
ZURICH (Reuters) - Novartis has been ‍granted priority review for its cell therapy Kymriah for adults with a form of lymphoma by the U.S. Food and Drug Administration, the Swiss drugmaker said on Wednesday, as it seeks to expand use of the treatment in multiple blood cancers. (Source: Reuters: Health)
Source: Reuters: Health - January 17, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Joachim Flickinger appointed as the new Managing Director of S. Karger GmbH in Freiburg, Germany
Joachim Flickinger took over responsibility for S. Karger GmbH in Freiburg, Germany, as the Managing Director. Alongside his new role he will continue to serve as Director Sales & Distribution and as a member of the Management Board of S. Karger AG in Basel, Switzerland. Sibylle Gross, who had been in charge of the Freiburg office since 1993, retired at the end of 2017. As the new Managing Director in Freiburg Joachim Flickinger will be contributing his knowledge and expertise in the areas of sales and market expansion. In future, one of the goals is to better connect the Freiburg and Basel offices to leverage synergie...
Source: News from STM - January 15, 2018 Category: Databases & Libraries Authors: STM Publishing News Tags: European Featured Source Type: news

Comparative analysis of bones, mites, soil chemistry, nematodes and soil micro-eukaryotes from a suspected homicide to estimate the post-mortem interval - Szelecz I, L ösch S, Seppey CVW, Lara E, Singer D, Sorge F, Tschui J, Perotti MA, Mitchell EAD.
Criminal investigations of suspected murder cases require estimating the post-mortem interval (PMI, or time after death) which is challenging for long PMIs. Here we present the case of human remains found in a Swiss forest. We have used a multidisciplinary... (Source: SafetyLit)
Source: SafetyLit - January 15, 2018 Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news

Roche's star MS medicine Ocrevus wins EU approval
ZURICH (Reuters) - The European Union approved Roche's multiple sclerosis medicine Ocrevus, one the Swiss company's key new drugs that likely neared $1 billion in revenue in its first nine months on the U.S. market. (Source: Reuters: Health)
Source: Reuters: Health - January 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Mobilizing agencies for incidence surveys on child maltreatment: successful participation in Switzerland and lessons learned - Jud A, Kosirnik C, Mitrovic T, Ben Salah H, Fux E, Koehler J, Portmann R, Kn üsel R.
BACKGROUND: Many countries around the world lack data on the epidemiology of agency response to child maltreatment. They therefore lack information on how many children in need get help and protection or if children stand equal chances across regions to ge... (Source: SafetyLit)
Source: SafetyLit - January 12, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Combining Cataract Surgery, Baerveldt-tube Implant Sometimes Useful for Glaucoma Combining Cataract Surgery, Baerveldt-tube Implant Sometimes Useful for Glaucoma
Cataract surgery and implantation of a Baerveldt tube (BT) for glaucoma should be done separately in most cases, but may be combined in some, research from Switzerland suggests.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 11, 2018 Category: Surgery Tags: Ophthalmology News Source Type: news

Study identifies brain circuit controlling social behavior
(Elsevier) A new study by researchers at Roche in Basel, Switzerland has identified a key brain region of the neural circuit that controls social behavior. Increasing the activity of this region, called the habenula, led to social problems in rodents, whereas decreasing activity of the region prevented social problems. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 11, 2018 Category: International Medicine & Public Health Source Type: news

Longer placements in general practice encourage doctors to choose GP careers
The majority of medical trainees who undertake additional training placements in general practice ultimately choose a career in the profession, a Swiss study has found. (Source: GP Online News)
Source: GP Online News - January 10, 2018 Category: Primary Care Tags: Practice News Source Type: news

Invitation to Roche's Full Year Results 2017 Presentation
Roche will publish its Full Year Results for 2017 prior to the opening of the Swiss Stock Exchange on Thursday, 1 February 2018. (Source: Roche Investor Update)
Source: Roche Investor Update - January 8, 2018 Category: Pharmaceuticals Source Type: news

Swiss biotech Oculis raises $21m for nanoparticle eye-drops
Swiss biotech Oculis has raised $21 million in a Series B round backed by investors including Novartis (NYSE:NVS) and Bay City Capital. The company is developing topical drugs for back-of-the-eye diseases, which are normally treated with painful injections directly into the eye. Get the full story at our sister site, Drug Delivery Business News. The post Swiss biotech Oculis raises $21m for nanoparticle eye-drops appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - January 5, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Funding Roundup Optical/Ophthalmic Pharmaceuticals Novartis Oculis Source Type: news

Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases
New Investors include Bay City Capital, Novartis Venture Fund and Pivotal bioVenture Partners LAUSANNE, Switzerland, January 4, 2018 -- (Healthcare Sales & Marketing Network) -- Oculis (www.oculis.com), a clinical-stage biotechnology company focused on... Biopharmaceuticals, Ophthalmology, Venture Capital Oculis , Diabetic Macular Edema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2018 Category: Pharmaceuticals Source Type: news

Sociodemographic information, aversive and traumatic events, offence-related characteristics, and mental health of delinquent women in forensic-psychiatric care in Switzerland - Krammer S, Eisenbarth H, Fallegger C, Liebrenz M, Klecha D.
The present study describes a much understudied group-namely, female prisoners under forensic-psychiatric care in the German-speaking part of Switzerland-to improve understanding of their risks and their needs. Data were derived from internal databases of ... (Source: SafetyLit)
Source: SafetyLit - January 3, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Novartis breast cancer therapy gets FDA breakthrough designation
ZURICH (Reuters) - Novartis's Kisqali (ribociclib) has won U.S. Food and Drug Administration breakthrough therapy designation for treating some breast cancer patients, the Swiss drugmaker said on Wednesday. (Source: Reuters: Health)
Source: Reuters: Health - January 3, 2018 Category: Consumer Health News Tags: healthNews Source Type: news